Enveric Biosciences to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th

Rhea-AI Summary

Enveric Biosciences (NASDAQ: ENVB), a biotechnology firm focused on mental health and oncology, announced that Dr. Joseph Tucker, CEO, will present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, 2021. The presentation will be available on-demand starting at 7:00 a.m. ET. This conference aims to showcase innovative treatments derived from psychedelics and synthetic cannabinoids, with Enveric's research targeting conditions like cancer-related distress and PTSD. Attendees can register to watch and schedule one-on-one meetings with management.

NAPLES, Fla., Nov. 29, 2021 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in the H.C. Wainwright 2^nd Annual Psychedelics Conference to be hosted virtually on Monday, December 6, 2021.

Dr. Tucker's corporate presentation will be available on-demand starting at 7:00 a.m. ET. Register to attend here.

For more information about the conference, or to schedule a one-on-one meeting with Enveric's management team, please contact your appropriate representative directly, or send an email to H.C. Wainwright at lk@hcwco.com, or KCSA Strategic Communications at EnvericBio@kcsa.com.

About Enveric Biosciences
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For more information, please visit www.enveric.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-the-hc-wainwright-2nd-annual-psychedelics-virtual-conference-on-december-6th-301431941.html

SOURCE Enveric Biosciences

FAQ

What is the date of Enveric Biosciences' presentation at the H.C. Wainwright Conference?

The presentation will take place on December 6, 2021.

Who is presenting for Enveric Biosciences at the conference?

Dr. Joseph Tucker, the CEO of Enveric Biosciences, will present.

What time will Enveric's presentation be available on-demand?

The presentation will be available on-demand starting at 7:00 a.m. ET.

What topics will Enveric Biosciences cover at the H.C. Wainwright Conference?

Enveric will discuss its developments in mental health and oncology using psychedelic-derived molecules and synthetic cannabinoids.

How can I register to attend Enveric Biosciences' presentation?

You can register to attend the presentation through the H.C. Wainwright conference website.